These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertension. Olsson KM; Richter MJ; Kamp JC; Gall H; Heine A; Ghofrani HA; Fuge J; Ewert R; Hoeper MM J Heart Lung Transplant; 2019 Jul; 38(7):748-756. PubMed ID: 31128966 [TBL] [Abstract][Full Text] [Related]
11. Rapid Titration of Intravenous Treprostinil to Treat Severe Pulmonary Arterial Hypertension Postpartum: A Retrospective Observational Case Series Study. Wang T; Lu J; Li Q; Chen Y; Ye Q; Gao J; Yang D; Zhao L; Huang J; Zhang J Anesth Analg; 2019 Dec; 129(6):1607-1612. PubMed ID: 31743181 [TBL] [Abstract][Full Text] [Related]
12. The Effect of Perioperative Administration of Treprostinil in Infants with Non-restrictive Ventricular Septal Defect and Severe Pulmonary Arterial Hypertension. Huang ST; Xu N; Sun KP; Chen LW; Cao H; Chen Q Pediatr Cardiol; 2020 Oct; 41(7):1334-1339. PubMed ID: 32468125 [TBL] [Abstract][Full Text] [Related]
13. Long-term effects of continuous prostacyclin therapy in adults with pulmonary hypertension associated with congenital heart disease. Thomas IC; Glassner-Kolmin C; Gomberg-Maitland M Int J Cardiol; 2013 Oct; 168(4):4117-21. PubMed ID: 23890862 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Echocardiographic Variables Prior to and Following Initiation of Parenteral Prostacyclin Therapy: An Observational Study. Shah T; Manthena P; Patel C; Chuah A; Hardin EA; Torres F; Bartolome SD; Chin KM Chest; 2022 Sep; 162(3):669-683. PubMed ID: 35460641 [TBL] [Abstract][Full Text] [Related]
15. Epoprostenol sodium for treatment of pulmonary arterial hypertension. Saito Y; Nakamura K; Akagi S; Sarashina T; Ejiri K; Miura A; Ogawa A; Matsubara H; Ito H Vasc Health Risk Manag; 2015; 11():265-70. PubMed ID: 25999730 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma. Farber HW; Graven KK; Kokolski G; Korn JH J Rheumatol; 1999 May; 26(5):1195-6. PubMed ID: 10332990 [TBL] [Abstract][Full Text] [Related]
17. Rapid initiation of intravenous epoprostenol infusion is the favored option in patients with advanced pulmonary arterial hypertension. Kimura M; Tamura Y; Takei M; Yamamoto T; Ono T; Kuwana M; Fukuda K; Satoh T PLoS One; 2015; 10(4):e0121894. PubMed ID: 25844932 [TBL] [Abstract][Full Text] [Related]
18. Transition from epoprostenol and treprostinil to the oral endothelin receptor antagonist bosentan in patients with pulmonary hypertension. Suleman N; Frost AE Chest; 2004 Sep; 126(3):808-15. PubMed ID: 15364760 [TBL] [Abstract][Full Text] [Related]